CV Sciences Statistics
Total Valuation
CV Sciences has a market cap or net worth of 5.82 million. The enterprise value is 6.15 million.
Market Cap | 5.82M |
Enterprise Value | 6.15M |
Important Dates
The last earnings date was Friday, March 28, 2025.
Earnings Date | Mar 28, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CV Sciences has 184.26 million shares outstanding. The number of shares has increased by 14.05% in one year.
Current Share Class | n/a |
Shares Outstanding | 184.26M |
Shares Change (YoY) | +14.05% |
Shares Change (QoQ) | +1.13% |
Owned by Insiders (%) | 0.02% |
Owned by Institutions (%) | n/a |
Float | 184.23M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.35 |
PB Ratio | 3.25 |
P/TBV Ratio | 7.97 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.57 |
EV / Sales | 0.39 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -7.00 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.43.
Current Ratio | 1.02 |
Quick Ratio | 0.16 |
Debt / Equity | 0.43 |
Debt / EBITDA | n/a |
Debt / FCF | -0.89 |
Interest Coverage | -5.54 |
Financial Efficiency
Return on equity (ROE) is -101.92% and return on invested capital (ROIC) is -24.79%.
Return on Equity (ROE) | -101.92% |
Return on Assets (ROA) | -8.57% |
Return on Invested Capital (ROIC) | -24.79% |
Return on Capital Employed (ROCE) | -64.58% |
Revenue Per Employee | 327,188 |
Profits Per Employee | -49,875 |
Employee Count | 43 |
Asset Turnover | 1.83 |
Inventory Turnover | 1.62 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.82% in the last 52 weeks. The beta is 0.63, so CV Sciences's price volatility has been lower than the market average.
Beta (5Y) | 0.63 |
52-Week Price Change | -16.82% |
50-Day Moving Average | 0.04 |
200-Day Moving Average | 0.04 |
Relative Strength Index (RSI) | 47.57 |
Average Volume (20 Days) | 179,572 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, CV Sciences had revenue of 15.71 million and -2.39 million in losses. Loss per share was -0.01.
Revenue | 15.71M |
Gross Profit | 7.17M |
Operating Income | -1.17M |
Pretax Income | -2.40M |
Net Income | -2.39M |
EBITDA | -840,000 |
EBIT | -1.17M |
Loss Per Share | -0.01 |
Balance Sheet
The company has 454,000 in cash and 779,000 in debt, giving a net cash position of -325,000 or -0.00 per share.
Cash & Cash Equivalents | 454,000 |
Total Debt | 779,000 |
Net Cash | -325,000 |
Net Cash Per Share | -0.00 |
Equity (Book Value) | 1.80M |
Book Value Per Share | 0.01 |
Working Capital | 134,000 |
Cash Flow
In the last 12 months, operating cash flow was -861,000 and capital expenditures -18,000, giving a free cash flow of -879,000.
Operating Cash Flow | -861,000 |
Capital Expenditures | -18,000 |
Free Cash Flow | -879,000 |
FCF Per Share | -0.00 |
Margins
Gross margin is 45.64%, with operating and profit margins of -7.48% and -15.24%.
Gross Margin | 45.64% |
Operating Margin | -7.48% |
Pretax Margin | -15.29% |
Profit Margin | -15.24% |
EBITDA Margin | -5.35% |
EBIT Margin | -7.48% |
FCF Margin | n/a |
Dividends & Yields
CV Sciences does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -14.05% |
Shareholder Yield | -14.05% |
Earnings Yield | -41.10% |
FCF Yield | -15.09% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CV Sciences has an Altman Z-Score of -13.06. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -13.06 |
Piotroski F-Score | n/a |